Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Ohio Bill Would Require Biological Father's Consent For Abortion
A bill (HR 252) introduced this month in the Ohio House would require a pregnant woman seeking an abortion to obtain written consent from the fetus" biological father, the Cincinnati Enquirer reports. If the woman does not know the identity of the biological father, she would have to provide proof of paternity tests of potential fathers. The bill is sponsored by Rep. John Adams (R) and co-sponsored by four other Republicans.The bill would establish "abortion fraud" as a first-degree misdemeanor, punishable by up to six months in jail and a fine of up to $1,000. Repeat offenders could be charged with a fifth-degree felony, punishable by up to one year in jail and up to a $2,500 fine. The bill is not clear as to who could be fined or jailed. Becki Brenner, president of Planned Parenthood of Southwest Ohio, said that she believes doctors would be the ones ultimately fined or jailed.Brenner criticized the bill, saying that a woman would have to pay at least $1,400 for each DNA test if she is unsure who the father is. Brenner called the legislation "a burden on a woman," adding that the whole purpose behind the bill is to make it harder to obtain a legal abortion. She said, "Hopefully, [the bill] won"t even get debate in the committee" because it is "blatantly anti-woman."Paula Westwood, executive director of Right to Life of Greater Cincinnati, said that her group supports the bill. She added, "I would think men would want to have these rights."According to the Enquirer, the bill does not have the support of the House Democratic majority. The current version of the bill has not been assigned to a committee, and it is unlikely to pass the House, much like past bills seeking new restrictions on abortion (Craig/Preston, Cincinnati Enquirer, 7/24).
generic viagra online
Long-term Health Effects Linked With Relationship Violence In Women's Adulthood
Experiences with relationship violence beyond the formative and developmental years of childhood and adolescence can have far-reaching effects on the health status of disadvantaged urban women, a new study shows.
News of the day
POZEN Submits New Drug Application For VIMOVO™ (PN 400)
POZEN Inc. (NASDAQ:POZN), announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of VIMOVO™ (PN 400), the combination of enteric coated (EC) naproxen and immediate release esomeprazole. POZEN and AstraZeneca entered into a global co-development agreement for VIMOVO in August 2006. Pending regulatory approval, the proposed trade name is VIMOVO and the proposed indications are for the signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis in patients who are at risk for developing NSAID-associated ulcers.
Endocrinology

2009 Recipient Of Minority Scholar Award Begins Clinical Research On Leukemia

Alejandro Gutierrez, MD, is the third recipient of the ASH-AMFDP grant, an award designed to help increase the number of underrepresented minority scholars in the field of hematology, and will begin his research into the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL) this month. The award, the result of a partnership between the American Society of Hematology (ASH) and the Harold Amos Medical Faculty Development Program (AMFDP) of the Robert Wood Johnson Foundation, provides four years of support, including an annual stipend of up to $75,000 and an annual grant of more than $29,000 for research activities. "I am truly honored to have been selected as the 2009 recipient of the ASH-AMFDP," said Dr. Gutierrez. "This award represents an outstanding career development opportunity for which I am most grateful, and I look forward to years of productive collaboration with ASH and the AMFDP." His research is entitled "Unraveling the Molecular Pathogenesis of T-Cell Acute Lymphoblastic Leukemia Using Zebrafish Genetics and Small Molecule Screens," and will focus on harnessing the strengths of the zebrafish model system to unravel the molecular pathogenesis of T-cell acute lymphoblastic leukemia. Specifically, Dr. Gutierrez is interested in identifying targetable molecular pathways that are required for the survival of MYC-overexpressing thymocytes using a zebrafish small molecule screen, and in uncovering the functional roles of novel T-ALL oncogenes and tumor suppressors in our zebrafish model of this disease. Dr. Gutierrez is currently Instructor in Pediatrics, Dana-Farber Cancer Institute, Children"s Hospital Boston, Harvard Medical School. For more information, please see the ASH-AMFDP page on the ASH Web site. The American Society of Hematology is the world"s largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In September, ASH launched Blood: The Vital Connection , a credible online re addressing bleeding and clotting disorders, anemia, and cancer. It provides hematologist-approved information about these common blood conditions including risk factors, preventive measures, and treatment options. The American Society of Hematology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009